MYCN and cancer: This indicates that MYCN gene amplification is an early and perhaps initiating event driving the development of a high-risk neuroblastoma subgroup of tumors which is in contrast to most other cancers where gene amplifications are considered to be late events during tumorigenesis (17, 27).